PubMed HealthSearch

PubMed · 7423358

Current development in Social Security financing.

Abstract

The current financial outlook for the old-age, survivors, disability, and health insurance (OASDHI) program indicates several problems. During 1980-84, income and outgo for the OASDI and hospital insurance (HI) trust funds combined are roughly in balance, according to the annual report of the Board of Trustees. The OSI program, however, is running out of funds as automatic benefit increases exceed the growth in payroll tax revenues. Clearly, additional financing will be needed throughout the 1980's. Funds now earmarked for the DI and HI trust funds could serve this purpose, although more short-range financing will be needed if real wages continue to show losses instead of the usual gains. The 1977 amendments that strengthened social security financing provided only a thin margin of safety against unfavorable experience during the early 1980's. The short-range economic picture has darkened considerably since 1977, with adverse consequences for social security financing. Only the DI experience has improved. Based on tax rates in the present law, a large buildup of OASDI trust funds is expected over the next 25 years. HI financing, however, is projected to become inadequate after 1990. Projections over the next 75 years indicate severe financing problems for the OASDI program early in the 21st centruy, as the aged population grows relative to the work force.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

D K Bartlett. 1980. Current development in Social Security financing.. https://pubmed.ncbi.nlm.nih.gov/7423358/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Influence of the implantable cardioverter/defibrillator on sudden death and total mortality in patients evaluated for cardiac transplantation.

BACKGROUND: Implantable cardioverter/defibrillators (ICDs) may reduce sudden tachyarrhythmic death in patients with severe left ventricular dysfunction. It is uncertain whether this improves survival, particularly in patients awaiting cardiac transplantation. METHODS AND RESULTS: The effect of treatment for spontaneous ventricular arrhythmias (ICD [n = 59], antiarrhythmic drugs [n = 53], or no antiarrhythmic treatment [n = 179]) on total mortality and mode of cardiac death was analyzed in 291 consecutive patients evaluated for cardiac transplantation between January 1986 and January 1995. There were 109 deaths (37.4%) (63 [21.6%] sudden, 40 [13.7%] nonsudden, and 6 [2.1%] noncardiac) during mean follow-up of 15 months (range, 1 to 118 months). Baseline clinical variables, medical therapies for heart failure, and actuarial rates of transplantation were similar between treatment groups. Kaplan-Meier sudden death rates were lowest in the ICD group, intermediate in the no antiarrhythmic treatment group, and highest in the drug treatment group throughout follow-up (12-month sudden death rates, 9.2%, 16.0%, and 34.7%, respectively; P = .004). Total mortality and nonsudden death rates did not differ. Cox proportional-hazards model revealed that antiarrhythmic drug treatment was associated with sudden death (relative risk, 2.1; 95% CI, 1.04 to 3.39; P = .04) and ICD was associated with nonsudden death (relative risk, 2.26; 95% CI, 1.12 to 4.62; P = .02). CONCLUSIONS: Sudden death rates were lowest in patients treated with ICDs compared with drug treatment or no antiarrhythmic treatment. However, although ICDs reduced sudden death in selected high-risk patients with severe left ventricular dysfunction, the effect on long-term survival was limited, principally by high nonsudden death rates.

Actuarial Analysis